Check out our latest industry white papers. Browse now!
Sales & Support: +1 800 762 3361
Member Resources

Fueled by a global pandemic and hundreds of millions of federal WARP SPEED dollars, Johnson & Johnson (J&J) is locking down a global manufacturing network to launch production if its COVID-19 vaccine candidate gets the regulatory green light. From Baltimore, Maryland, to Leiden, Netherlands, the pharma giant has expanded beyond its own already substantial means to partner with contract development manufacturing organizations (CDMOs) Emergent and Catalent. It is important to note that many of the sites are either in the midst of an expansion or already have substantial capacity in place and will be expanding to 24/7 shifts. Industrial Info is tracking a combined 111 plants and 103 projects belonging to these companies. Click here for a list of plants and here for a list of projects. See map below.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!